Purple Biotech (PPBT) Current Leases (2019 - 2021)

Purple Biotech (PPBT) has disclosed Current Leases for 3 consecutive years, with $199000.0 as the latest value for Q4 2021.

  • On a quarterly basis, Current Leases fell 3.86% to $199000.0 in Q4 2021 year-over-year; TTM through Dec 2021 was $199000.0, a 3.86% decrease, with the full-year FY2021 number at $199000.0, down 3.86% from a year prior.
  • Current Leases was $199000.0 for Q4 2021 at Purple Biotech, down from $207000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $207000.0 in Q4 2020 to a low of $195000.0 in Q4 2019.
  • A 3-year average of $200333.3 and a median of $199000.0 in 2021 define the central range for Current Leases.
  • Peak YoY movement for Current Leases: increased 6.15% in 2020, then dropped 3.86% in 2021.
  • Purple Biotech's Current Leases stood at $195000.0 in 2019, then rose by 6.15% to $207000.0 in 2020, then fell by 3.86% to $199000.0 in 2021.
  • Per Business Quant, the three most recent readings for PPBT's Current Leases are $199000.0 (Q4 2021), $207000.0 (Q4 2020), and $195000.0 (Q4 2019).